Larvol Delta - Characterization-of-Weight-Loss-with-Nerandomilast-in-Patients-with-Autoimmune-Interstitial-Lung-Disease-and-Progressive-Pulmonary-Fibrosis-in-the-FIBRONEERILD-Trial

Jascayd (nerandomilast) - Boehringer Ingelheim

https://eppro02.ativ.me/web/page.php?nav=false&page=Session&project=ACR26&id=3568705

Anna-Maria Hoffmann-Vold, MD, PhD

Sep 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next